P2RY6 and neurodegenerative disease: Based on our data and published literature, we propose that blocking of P2RY6-mediated signaling can indeed reduce neuroinflammation and might induce HSP expression and CMA activity (Figure 5), which are all considered advantageous during neurodegenerative diseases (49–52).